| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Bellerophon Therapeutics, Inc. | Director | Stock Options (Right to Buy) | 14,607 | $22,203 | $1.52 | 07 Jun 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| BLPH | Bellerophon Therapeutics, Inc. | 07 Jun 2023 | 1 | $0 | 4 | Director | 09 Jun 2023, 16:11 |
| BLPH | Bellerophon Therapeutics, Inc. | 10 Feb 2023 | 1 | $44,080 | 4 | Director | 14 Feb 2023, 15:45 |
| BLPH | Bellerophon Therapeutics, Inc. | 31 Dec 2021 | 1 | $67,666 | 4 | Director | 04 Jan 2022, 15:10 |